Endometrial carcinoma, often referred to as endometrial cancer, is a type of cancer that originates in the lining of the uterus (endometrium). It is the most common gynecologic cancer in developed countries, with the majority of cases diagnosed in postmenopausal women.
What Causes Endometrial Carcinoma?
The exact cause of endometrial carcinoma is unknown, but the disease has been strongly linked to hormonal imbalances, particularly an excess of estrogen relative to progesterone. This imbalance can cause the endometrial cells to grow abnormally and lead to cancer over time. Key factors contributing to this hormonal imbalance and increasing the risk of endometrial cancer include:
Obesity: Excess fat tissue increases estrogen production, creating an environment conducive to cancer development.
Hormone Replacement Therapy (HRT): Prolonged use of estrogen-only hormone replacement therapy without progesterone increases risk.
Polycystic Ovary Syndrome (PCOS): This condition often leads to irregular ovulation and higher levels of circulating estrogen.
Diabetes: Metabolic disturbances linked to diabetes may promote carcinogenic changes in the endometrium.
Genetic Predisposition: Lynch syndrome and mutations in mismatch repair genes significantly increase the risk.
Reproductive History: Never having been pregnant, late menopause, and early onset of menstruation contribute to prolonged estrogen exposure.
How to Lower Risks of Endometrial Carcinoma
While not all cases are preventable, several lifestyle and medical strategies can reduce the risk of developing endometrial carcinoma:
Maintain a Healthy Weight: Regular exercise and a balanced diet help regulate hormones and reduce obesity-related risks.
Use of Combined Hormonal Contraceptives: Birth control pills that combine estrogen and progesterone have a protective effect against endometrial cancer.
Manage Diabetes: Proper control of blood sugar and weight can help lower risks.
Consider Prophylactic Surgery in High-Risk Individuals: Women with Lynch syndrome may opt for a hysterectomy to prevent cancer.
Regular Checkups: Postmenopausal women with abnormal bleeding should seek early evaluation, as this is a common early symptom.
Survival Rate and Prognosis
Endometrial carcinoma is often diagnosed early because abnormal uterine bleeding is a noticeable symptom, even in its early stages. The 5-year survival rate for endometrial cancer depends on the stage at diagnosis:
Stage I (confined to the uterus): About 95%.
Stage II (spread to cervical tissue): Approximately 70-80%.
Stage III (spread to nearby structures or lymph nodes): Around 50-60%.
Stage IV (distant metastases): About 20%.
Treatment Options
Treatment for endometrial carcinoma varies based on the stage, grade, and patient-specific factors:
Surgery: A hysterectomy (removal of the uterus) is the primary treatment for most cases. Removal of ovaries and fallopian tubes (bilateral salpingo-oophorectomy) is also common.
Radiation Therapy: Often used after surgery to target remaining cancer cells or as a primary treatment in cases where surgery isn’t an option.
Hormonal Therapy: Used for advanced or recurrent cases, particularly in patients with hormone-receptor-positive cancers.
Chemotherapy: Effective for advanced stages or aggressive histological types like serous or clear cell carcinoma.
Immunotherapy: Emerging treatments such as checkpoint inhibitors are showing promise for advanced cases.
Prognosis
The prognosis for endometrial carcinoma is generally favorable when detected early. Early-stage disease confined to the uterus has an excellent outlook, especially when appropriate treatment is administered promptly. Aggressive subtypes or cases diagnosed at advanced stages carry a poorer prognosis, necessitating more intensive treatments.
Conclusion
Endometrial carcinoma remains one of the most treatable cancers when identified early. Awareness of risk factors, early symptoms such as abnormal bleeding, and regular gynecological checkups can significantly improve outcomes. By adopting a healthy lifestyle and seeking prompt medical advice, women can reduce their risk and increase the likelihood of successful treatment.
